Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Effect of medroxy progesterone acetate and testosterone enanthate on vas deferens of rats

Rao, M.V.; Roy, G.K.; Prasannalata, S.N.

Indian Journal of Experimental Biology 36(2): 157-161

1998

ISSN/ISBN: 0019-5189
PMID: 9754044
Document Number: 242
Effects of medroxy progesterone acetate (MPA; 5 mg/kg) and MPA + testosterone enanthate (TE) (3 mg + 2 mg/kg) were investigated in vas deferens and on fertility (along with reversibility study) for 60 days through histopathology, morphometric and certain biochemical parameters such as total proteins, sialic acid, ATPase, SDH and testosterone. The study revealed for altered histopathology and contratile pattern of vas deferens resulting in reduced fertility. The study also indicated androgen antagonistic effect. These effects were found to be reversible 4 and 3 months after withdrawal of MPA and MPA + TE injections respectively. Thus, both types generated functional sterility in the rat, but MPA affected histophysiology of vasal tissue.

Document emailed within 1 workday
Secure & encrypted payments

Effect of medroxy progesterone acetate and testosterone enanthate on vas deferens of rats

Bandopadhyaya, G.P.; Das, R.P.; Roy, S. 1976: Effect of a low dose of medroxy progesterone acetate on the reproductive organs and fertility of male rats Indian Journal of Medical Research 64(4): 518-522
Bandopadhyaya, G.P.; Das, R.P.; Roy, S. 1976: Effect of a low dose of medroxy progesterone acetate on the reproductive organs and fertility of male rats Indian Journal of Medical Research 64(4): 518-522
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Lohiya, N.K.; Sharma, R.C. 1983: Contraception with danazol plus testosterone enanthate in the rabbit. I. Effects on vas deferens Acta Europaea Fertilitatis 14(4): 269-272
el-Mahgoub, S.; Karim, M.; Ammar, R. 1972: Long-term use of depot medroxy progesterone acetate as a contraceptive Acta Obstetricia et Gynecologica Scandinavica 51(3): 251-255
Saxena, B.N.; Dusitsin, N.; Tankeyoon, M.; Chaudhury, R.R. 1980: Return of ovulation after the cessation of depot-medroxy progesterone acetate treatment in Thai women Journal of the Medical Association of Thailand 63(2): 66-69
Taneepanichskul, S.; Patrachai, S. 1998: Effects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activity Journal of the Medical Association of Thailand 81(12): 944-946
Meriggiola, M.C.; Bremner, W.J.; Costantino, A.; Di Cintio, G.; Flamigni, C. 1998: Low dose of cyproterone acetate and testosterone enanthate for contraception in men Human Reproduction 13(5): 1225-1229
Melo, J.F.; Coutinho, E.M. 1977: Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate Contraception 15(6): 627-634
Yamada, T.; Yuyama, Y.; Okazaki, Y. 2004: A long-surviving patient with Stage IV breast cancer with no recurrence after combined therapy of medroxy progesterone acetate (MPA) and intra-arterial infusion chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1387-1389
Glucksmann, A.; Cherry, C.P. 1968: The effect of oestrogens, testosterone and progesterone on the induction of cervico-vaginal tumours in intact and castrate rats British Journal of Cancer 22(3): 545-562
Botella, J.; Duranti, E.; Viader, V.; Duc, I.; Delansorne, R.; Paris, J. 1995: Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells Journal of Steroid Biochemistry and Molecular Biology 55(1): 77-84
Jean-Faucher, C.; Berger, M.; de Turckheim, M.; Veyssière, G.; Jean, C. 1976: Effect of neonatal injections of estradiol, testosterone and cryproterone acetate on plasma and testicular testosterone and on the genital system in adult male mice Archives d'Anatomie Microscopique et de Morphologie Experimentale 65(1): 37-46
Beksinska, M.E.; Kleinschmidt, I.; Smit, J.A.; Farley, T.M.M. 2009: Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate Contraception 79(5): 345-349
Wallace, E.M.; Gow, S.M.; Wu, F.C. 1993: Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations Journal of Clinical Endocrinology and Metabolism 77(1): 290-293
Scheuer, A.; Dahnke, H.G.; Mosebach, K.O. 1971: Changes in nuleic acid concentrations in some organs of growing male rats and their influencing by cyproterone acetate and testosterone Acta Endocrinologica. Supplementum 152: 34